Home Newsfeeds Bloomberg Reported SVB’s MoffettNathanson Research Unit Expects Business To Continue As Normal

News

Bloomberg Reported SVB’s MoffettNathanson Research Unit Expects Business To Continue As Normal

https://www.bloomberg.com/news/articles/2023-03-12/svb-research-unit-expects-business-to-continue-as-normal?sref=y3YMCJ4e&leadSource=uverify%20wall

byCharles Gross

March 12, 2023

1 minute read

https://www.bloomberg.com/news/articles/2023-03-12/svb-research-unit-expects-business-to-continue-as-normal?sref=y3YMCJ4e&leadSource=uverify%20wall

Baijiayun Group Ltd Reports Financial Results For First Half Of FY23; 1H 23 Revenue $40.9M

By Happy Mohamed

April 18, 4:38 PM

Financial Highlights for the First Half of Fiscal Year 2023 Total revenues increased by 32.2% period-over-period to $40.9 million for 1HFY23 Gross margin was 17.7% for 1HFY23, compared

RTC

Tarsus Pharmaceuticals, Inc. Announces That XDEMVY 0.25% Is Now Available At Pharmacies Nationwide For Prescription. The U.S. FDA Approved Drug On July 24, 2023, For The Treatment Of Demodex Blepharitis

By Happy Mohamed

August 24, 9:11 AM

Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY is indicated for all adult patients with Demodex blepharitis and is available via

TARS

Will Apple’s Vision Pro Give Goldman Sachs A Headache? Mark Gurman Does The ‘$1B Loan’ Math

By Ananya Gairola

January 18, 11:10 AM

Tech analyst Mark Gurman humorously predicts a significant financial impact on Goldman Sachs if Apple Card users choose installment plans for the new Apple Vision Pro headset.

AAPL